Search Results

Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid Agonists

Authors: Gerra, Gilberto; Zaimovic, Amir; Gerra, Maria L.; Ciccocioppo, Roberto; Cippitelli, Andrea; Serpelloni, Giovanni; Somaini, Lorenzo

Source: Recent Patents on CNS Drug Discovery, Volume 5, Number 1, January 2010 , pp. 46-52(7)

Publisher: Bentham Science Publishers

New Frontiers in Alcoholism and Addiction Treatment

Authors: Nava, Felice; Vendramin, Andrea; Manzato, Ezio; Cibin, Mauro; Lucchini, Alfio

Source: Recent Patents on CNS Drug Discovery, Volume 5, Number 1, January 2010 , pp. 81-94(14)

Publisher: Bentham Science Publishers

Palatable High-Energy Diet Decreases the Expression of Cannabinoid Type 1 Receptor Messenger RNA in Specific Brain Regions in the Rat

Authors: Timofeeva, E.; Baraboi, E.-D.; Poulin, A.-M.; Richard, D.

Source: Journal of Neuroendocrinology, Volume 21, Number 12, December 2009 , pp. 982-992(11)

Publisher: Blackwell Publishing

Cannabinoid hyperemesis

Source: Internal Medicine Journal, Volume 39, Number 11, November 2009 , pp. 777-778(2)

Publisher: Blackwell Publishing

G Protein-Coupled Receptors: Target-Based In Silico Screening

Authors: Senderowitz, Hanoch; Marantz, Yael

Source: Current Pharmaceutical Design, Volume 15, Number 35, December 2009 , pp. 4049-4068(20)

Publisher: Bentham Science Publishers

Editorial [Hot topic: Endocannabinoid Receptor System (Guest Editor: Robyn A. Puffenbarger)]

Author: Puffenbarger, Robyn A.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 402-402(1)

Publisher: Bentham Science Publishers

The Endocannabinoid System and Pain

Authors: Guindon, Josee; Hohmann, Andrea G.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 403-421(19)

Publisher: Bentham Science Publishers

Signal Transduction via Cannabinoid Receptors

Authors: Dalton, George D.; Bass, Caroline E.; Van Horn, Cynthia G.; Howlett, Allyn C.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 422-431(10)

Publisher: Bentham Science Publishers

Cannabinoids and Parkinson's Disease

Authors: Garcia-Arencibia, Moises; Garcia, Concepcion; Fernandez-Ruiz, Javier

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 432-439(8)

Publisher: Bentham Science Publishers

Cannabinoids and Neurodegenerative Diseases

Authors: Romero, Julian; Martinez-Orgado, Jose

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 440-450(11)

Publisher: Bentham Science Publishers

The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders

Authors: Hill, Matthew N.; Gorzalka, Boris B.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 451-458(8)

Publisher: Bentham Science Publishers

Cannabinoids, multiple sclerosis and neuroprotection

Authors: de Lago, Eva; Gómez-Ruiz, María; Moreno-Martet, Miguel; Fernández-Ruiz, Javier

Source: Expert Review of Clinical Pharmacology, Volume 2, Number 6, November 2009 , pp. 645-660(16)

Publisher: Expert Reviews

Do Δ⁹-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?

Authors: Karschner, Erin L.; Schwilke, Eugene W.; Lowe, Ross H.; Darwin, W. David; Pope, Harrison G.; Herning, Ronald; Cadet, Jean L.; Huestis, Marilyn A.

Source: Addiction, Volume 104, Number 12, December 2009 , pp. 2041-2048(8)

Publisher: Blackwell Publishing

Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating κ-opioid and cannabinoid receptors

Authors: fichna, j.; schicho, r.; andrews, c. n.; bashashati, m.; klompus, m.; mckay, d. m.; sharkey, k. a.; zjawiony, j. k.; janecka, a.; storr, m. a.

Source: Neurogastroenterology and Motility, Volume 21, Number 12, December 2009 , pp. 1326-e128(-1325)

Publisher: Blackwell Publishing

Cannabinoids as novel anti-inflammatory drugs

Authors: Nagarkatti, Prakash; Pandey, Rupal; Rieder, Sadiye Amcaoglu; Hegde, Venkatesh L; Nagarkatti, Mitzi

Source: Future Medicinal Chemistry, Volume 1, Number 7, October 2009 , pp. 1333-1349(17)

Publisher: Future Science

The cannabinoid R(+)methanandamide induces IL-6 secretion by prostate cancer PC3 cells

Authors: Olea-Herrero, Nuria; Vara, Diana; Malagarie-Cazenave, Sophie; Díaz-Laviada, Inés

Source: Journal of Immunotoxicology, Volume 6, Number 4, December 2009 , pp. 249-256(8)

Publisher: Informa Healthcare

Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test

Authors: Barbano, Maria; Castañé, Anna; Martín-García, Elena; Maldonado, Rafael

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 475-487(13)

Publisher: Springer

Implications of Plasma Δ⁹-Tetrahydrocannabinol, 11-Hydroxy-THC, and 11-nor-9-Carboxy-THC Concentrations in Chronic Cannabis Smokers

Authors: Karschner, Erin L.; Schwilke, Eugene W.; Lowe, Ross H.; Darwin, W. David; Herning, Ronald I.; Cadet, Jean Lud; Huestis, Marilyn A.

Source: Journal of Analytical Toxicology, Volume 33, Number 8, October 2009 , pp. 469-477(9)

Publisher: Preston Publications

Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats

Authors: Gardiner, SM; March, JE; Kemp, PA; Bennett, T

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 1143-1152(10)

Publisher: Blackwell Publishing

Cannabis smoke condensate III: The cannabinoid content of vaporised Cannabis sativa

Authors: Pomahacova, B.; Van der Kooy, F.; Verpoorte, R.

Source: Inhalation Toxicology, Volume 21, Number 13, November 2009 , pp. 1108-1112(5)

Publisher: Informa Healthcare